ZY Jan 2024 2.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:24AM EST. Market open.
| Previous close | 0.8500 |
| Open | 0.8500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 2.50 |
| Expiry date | 2024-01-19 |
| Day's range | 0.8500 - 0.8500 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.47k |
- PR Newswire
Ginkgo Bioworks Completes Acquisition of Zymergen
Today, Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, and Zymergen (Nasdaq: ZY) announced that Ginkgo has completed its previously announced acquisition of Zymergen. The acquisition is expected to significantly enhance Ginkgo's platform by integrating strong automation and software capabilities as well as a wealth of experience across diverse biological engineering approaches.
- Motley Fool
Why Biotech Disruptor Ginkgo Bioworks Is Well-Positioned for the Future
Beaten down from its highs late last year, cell engineering company Ginkgo Bioworks now looks primed to divide and conquer.
© 2023 Yahoo. All rights reserved.
